Tennessee · 114th Regular Session (2025-2026) · Bill

SB 1495: Opioids - As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.

Enacted Last action May 18, 2026: Pub. Ch. 888

Plain-language summary

SB 1495 is a bill introduced in the Tennessee Senate on December 23, 2025. According to its official title, it concerns: Opioids - As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33. Primary sponsor: Ferrell Haile (Republican). Most recent recorded action (May 18, 2026): Pub. Ch. 888.

Sponsors

Primary sponsor: Ferrell Haile (Republican).